Hearing:
“The Cost of Being a Public Company in Light of Sarbanes-Oxley and the Federalization of Corporate Governance”
Subcommittee on Capital Markets, Securities, and Investment (Committee on Financial Services)
Tuesday, July 18, 2017 (10:00 AM)
2128 RHOB
Washington, D.C.
Witnesses
Mr. Thomas Farley
President, NYSE Group
Added
07/18/2017 at 01:59 PM
- Witness Statement
[PDF]
Added
07/18/2017 at 02:00 PM
- Witness Truth in Testimony
[PDF]
Added
07/19/2017 at 04:04 PM
Mr. John Blake
Senior Vice President of Finance, aTyr Pharma, Inc.
Added
07/18/2017 at 01:59 PM
- Witness Statement
[PDF]
Added
07/18/2017 at 02:00 PM
- Witness Truth in Testimony
[PDF]
Added
07/19/2017 at 04:04 PM
Mr. Thomas Quaadman
Executive Vice President, Center for Capital Market Competitiveness, U.S. Chamber of Commerce
Added
07/18/2017 at 01:59 PM
- Witness Statement
[PDF]
Added
07/18/2017 at 02:00 PM
- Witness Truth in Testimony
[PDF]
Added
07/19/2017 at 04:04 PM
Professor J. Robert Brown Jr.
Lawrence W. Treece Professor of Corporate Governance, Director, Corporate and Commercial Law Program, University of Denver Sturm College of Law
Added
07/18/2017 at 01:59 PM
- Witness Statement
[PDF]
Added
07/18/2017 at 02:00 PM
- Witness Truth in Testimony
[PDF]
Added
07/19/2017 at 04:04 PM
Mr. John Berlau
Senior Fellow, Competitive Enterprise Institute
Added
07/18/2017 at 01:59 PM
- Witness Statement
[PDF]
Added
07/18/2017 at 02:00 PM
- Witness Truth in Testimony
[PDF]
Added
07/19/2017 at 04:04 PM
First Published:
July 14, 2017 at 04:20 PM
Last Updated:
July 19, 2017 at 04:04 PM